Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells
暂无分享,去创建一个
Joël Doré | J. Doré | H. Blottière | T. de Wouters | N. Lapaque | Malgorzata Nepelska | Fabienne Béguet-Crespel | Hervé M. Blottière | Tomas de Wouters | Elsa Jacouton | Nicolas Lapaque | Velmurugesan Arulampalam | V. Arulampalam | Fabienne Béguet-Crespel | M. Nepelska | Elsa Jacouton | Tomas de Wouters
[1] G. Zhou,et al. Insulin- and Mitogen-activated Protein Kinase-mediated Phosphorylation and Activation of Peroxisome Proliferator-activated Receptor γ* , 1996, The Journal of Biological Chemistry.
[2] R. Hughes,et al. Fecal Water as a Non-Invasive Biomarker in Nutritional Intervention: Comparison of Preparation Methods and Refinement of Different Endpoints , 2007, Nutrition and cancer.
[3] J. Gustafsson,et al. Decreased Fat Storage by Lactobacillus Paracasei Is Associated with Increased Levels of Angiopoietin-Like 4 Protein (ANGPTL4) , 2010, PloS one.
[4] U. Vogel,et al. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease. , 2011, World journal of gastroenterology.
[5] M. Mohammadi,et al. Faculty Opinions recommendation of Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[6] J. Doré,et al. Identification of NF-κB Modulation Capabilities within Human Intestinal Commensal Bacteria , 2011, Journal of biomedicine & biotechnology.
[7] G. Macfarlane,et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.
[8] F. Bäckhed,et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. , 2013, Cell metabolism.
[9] Malcolm J. McConville,et al. MR1 presents microbial vitamin B metabolites to MAIT cells , 2012, Nature.
[10] Wei Sun,et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. , 2011, Cell metabolism.
[11] Patrice D Cani,et al. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. , 2008, Pathologie-biologie.
[12] N. Cerf-Bensussan,et al. The immune system and the gut microbiota: friends or foes? , 2010, Nature Reviews Immunology.
[13] Philippe Chavatte,et al. PPARγ as a new therapeutic target in inflammatory bowel diseases , 2006, Gut.
[14] M. Lazar,et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. , 1999, The Journal of clinical investigation.
[15] M. Lazar,et al. Modulating nuclear receptor function: may the phos be with you. , 1999, The Journal of clinical investigation.
[16] P. Bork,et al. Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.
[17] S. Ganguly,et al. Gut microbiota in health and disease , 2019, APIK Journal of Internal Medicine.
[18] J. Doré,et al. ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[19] Anders K. Haakonsson,et al. Short-Chain Fatty Acids Stimulate Angiopoietin-Like 4 Synthesis in Human Colon Adenocarcinoma Cells by Activating Peroxisome Proliferator-Activated Receptor γ , 2013, Molecular and Cellular Biology.
[20] Samuel Singer,et al. Differentiation and reversal of malignant changes in colon cancer through PPARγ , 1998, Nature Medicine.
[21] C. Huttenhower,et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis , 2013, eLife.
[22] M. Moeschberger,et al. New Bacterial Species Associated with Chronic Periodontitis , 2003, Journal of dental research.
[23] 生島 仁史,et al. 放射線治療--state of the art and in future , 2009 .
[24] P. Sansonetti,et al. A Crypt-Specific Core Microbiota Resides in the Mouse Colon , 2012, mBio.
[25] R. Wolff,et al. PPARγ and Colon and Rectal Cancer: Associations with Specific Tumor Mutations, Aspirin, Ibuprofen and Insulin-Related Genes (United States) , 2006, Cancer Causes & Control.
[26] Christine Dreyer,et al. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.
[27] V. Annese,et al. PPARγ in Inflammatory Bowel Disease , 2012, PPAR research.
[28] K. Morimura,et al. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. , 2006, Gut.
[29] Jonathan R. Brestoff,et al. Commensal bacteria at the interface of host metabolism and the immune system , 2013, Nature Immunology.
[30] J. V. Vanden Heuvel,et al. Modulation of PPAR activity via phosphorylation. , 2007, Biochimica et biophysica acta.
[31] M. Icaza-Chávez,et al. Gut microbiota in health and disease , 2013 .
[32] S. Ferrari,et al. Author contributions , 2021 .
[33] Jiahuai Han,et al. Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.
[34] J. Cummings. Microbial Digestion of Complex Carbohydrates in Man , 1984, Proceedings of the Nutrition Society.
[35] J. Gustafsson,et al. Enterococcus faecalis from newborn babies regulate endogenous PPARγ activity and IL-10 levels in colonic epithelial cells , 2008, Proceedings of the National Academy of Sciences.
[36] X. Thuru,et al. PPARgamma as a new therapeutic target in inflammatory bowel diseases. , 2006, Gut.
[37] J. Doré,et al. Commensal Streptococcus salivarius Modulates PPARγ Transcriptional Activity in Human Intestinal Epithelial Cells , 2015, PloS one.
[38] Ting Wang,et al. The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] W. Wahli,et al. Fat poetry: a kingdom for PPAR gamma. , 2007, Cell research.
[40] S. Lalevée,et al. Phosphorylation control of nuclear receptors. , 2010, Methods in molecular biology.
[41] J. Auwerx,et al. The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene* , 1997, The Journal of Biological Chemistry.
[42] Jeffrey I. Gordon,et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.
[43] M. Lazar,et al. Transcriptional Activation by Peroxisome Proliferator-activated Receptor γ Is Inhibited by Phosphorylation at a Consensus Mitogen-activated Protein Kinase Site* , 1997, The Journal of Biological Chemistry.
[44] S. Pettersson,et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.
[45] J. Gordon,et al. How host-microbial interactions shape the nutrient environment of the mammalian intestine. , 2002, Annual review of nutrition.
[46] M. Delday,et al. Microbes and microbial effector molecules in treatment of inflammatory disorders , 2012, Immunological reviews.
[47] J. Doré,et al. Human intestinal metagenomics: state of the art and future. , 2013, Current opinion in microbiology.
[48] C. Marshall,et al. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.
[49] Jeremy K. Nicholson,et al. Gut microbiota: a potential new territory for drug targeting , 2008, Nature Reviews Drug Discovery.
[50] W. Wahli,et al. Fat poetry: a kingdom for PPARγ , 2007, Cell Research.
[51] B. Spiegelman,et al. Loss-of-function mutations in PPAR gamma associated with human colon cancer. , 1999, Molecular cell.
[52] B. Spiegelman,et al. Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer , 1999 .
[53] K. Morimura,et al. Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease , 2005, Gut.
[54] A. Nakajima,et al. PPARγ and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease , 2001 .
[55] V. Mathan,et al. Vitamin B12 synthesis by human small intestinal bacteria , 1980, Nature.
[56] Joël Doré,et al. Butyrate Produced by Commensal Bacteria Potentiates Phorbol Esters Induced AP-1 Response in Human Intestinal Epithelial Cells , 2012, PloS one.